Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
Study on Continuing Elotuzumab Treatment for Patients with Multiple Myeloma from Previous Trials
Not recruiting
Investigated Diseases:Investigated Drugs:
Long-Term Access to Ibrutinib for Patients with Lymphoma, Leukemia, and Other Conditions
Not recruiting
Investigated Drugs:
+1
Study Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
+8
Study of Belantamab Mafodotin Alone and with Drug Combination for Patients with Relapsed/Refractory Multiple Myeloma
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
Not recruiting
Investigated Diseases:Investigated Drugs:
Comparison of allogeneic stem cell transplantation versus conventional therapy in patients with multiple myeloma who relapsed after first-line therapy
Not recruiting
Investigated Diseases:Investigated Drugs:
Study Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
Not recruiting
Investigated Diseases:Investigated Drugs:
+2
